HomeRAPT • NASDAQ
add
Rapt Therapeutics Inc
Previous close
$2.89
Day range
$2.81 - $3.06
Year range
$2.81 - $27.35
Market cap
112.02M USD
Avg Volume
576.09K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 32.52M | 3.03% |
Net income | -30.52M | -4.27% |
Net profit margin | — | — |
Earnings per share | -0.79 | -3.95% |
EBITDA | -32.20M | -3.01% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 141.58M | -38.88% |
Total assets | 155.82M | -37.25% |
Total liabilities | 24.98M | -10.31% |
Total equity | 130.84M | — |
Shares outstanding | 34.90M | — |
Price to book | 0.77 | — |
Return on assets | -49.40% | — |
Return on capital | -55.85% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -30.52M | -4.27% |
Cash from operations | -27.08M | -45.60% |
Cash from investing | 15.89M | -37.23% |
Cash from financing | 9.04M | 7,689.66% |
Net change in cash | -2.16M | -131.68% |
Free cash flow | -19.31M | -136.96% |
About
Founded
2015
Headquarters
Website
Employees
126